Article ; Online: Cost and health impact analysis of herpes zoster vaccination in Norway.
Expert review of pharmacoeconomics & outcomes research
2021 Volume 22, Issue 2, Page(s) 315–326
Abstract: Background: A decision analytic model was developed to estimate the cost-effectiveness of a national vaccination program against herpes zoster in Norway.: Methods: The model analyzed six vaccination scenarios that included the live-attenuated zoster ... ...
Abstract | Background: A decision analytic model was developed to estimate the cost-effectiveness of a national vaccination program against herpes zoster in Norway. Methods: The model analyzed six vaccination scenarios that included the live-attenuated zoster vaccine under different target ages of vaccination (60, 65, and 70 years) compared with no vaccination. A catch-up program implemented in the first year of the vaccination was included in three of the scenarios. The model followed the population of Norway over a 40-year time horizon to estimate costs and outcomes associated with vaccination. Immunization costs, costs related to herpes zoster (both healthcare sector and non-healthcasre sector), the quality of life gains due to avoided cases of herpes zoster, and quality-of-life losses due to vaccine-related adverse events were estimated. Results and conclusions: A national vaccination program would result in reduction of the number of herpes zoster cases and decreased burden of illness. Vaccinating adults at 65 years of age with catch-up up to 70 years in the first year of the program was the most cost-effective strategy with the incremental cost per quality-adjusted life-year gained at NOK (Norwegian Krone) 245,459 from the societal perspective and NOK 248,637 from the health care system perspective. |
---|---|
MeSH term(s) | Cost-Benefit Analysis ; Herpes Zoster/epidemiology ; Herpes Zoster/prevention & control ; Herpes Zoster Vaccine ; Humans ; Quality of Life ; Quality-Adjusted Life Years ; Vaccination |
Chemical Substances | Herpes Zoster Vaccine |
Language | English |
Publishing date | 2021-09-12 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 2208481-2 |
ISSN | 1744-8379 ; 1473-7167 |
ISSN (online) | 1744-8379 |
ISSN | 1473-7167 |
DOI | 10.1080/14737167.2021.1973893 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6194: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.